The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.

Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...

An analyst who attended the Heart Rhythm Society meeting in San Francisco (May 4-7) believes that Medtronic is likely charging $3,000 more for the Revo SureScan MR Conditional pacemaker than previous ...

A pacemaker from Medtronic, newly approved by the Food and Drug Administration, allows patients to securely transmit data from the pacemaker to their physicians via a smartphone or tablet using ...

Sixty-seven years ago on Halloween, a rolling power outage wreaked havoc across the Twin Cities and at the University of Minnesota hospital, where cardiac patients were relying on electrical ...

Today, that spirit continues to be the driving force behind much of what the company does—and has spearheaded a thriving ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. In 1958 Earl Bakken an electrical ...

Payment fulfills previously disclosed funding commitment of $20 million and supports planned completion of the BACKBEAT Global Pivotal Trial ...

Medtronic warns of older pacemaker wires Medtronic Inc. sent doctors around the world a letter Monday telling them about potential issues with wires in some older pacemakers that affect about 37,000 ...